🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Willis Towers Watson share rated a Buy on strong Q2 earnings

EditorAhmed Abdulazez Abdulkadir
Published 07/26/2024, 06:27 AM
WTW
-

On Friday, Willis Towers Watson (NASDAQ:WTW) received an optimistic update from Roth/MKM as the firm's analyst increased the price target on the company's shares to $315 from the previous $300, while reiterating a Buy rating. This adjustment follows the announcement of Willis Towers Watson's second-quarter earnings, which surpassed both the consensus estimate and the firm's own projections.

The company reported an adjusted earnings per share (EPS) of $2.55, which exceeded the consensus estimate of $2.32 and the analyst's expectation of $2.18. Organic growth for the quarter was reported at 6%, aligning with market predictions. In response to these results, Willis Towers Watson has revised its financial outlook upwards, raising the lower end of the guidance for adjusted operating margin and adjusted EPS. Additionally, the company has increased its target for annual cost savings.

The rationale behind the raised price target to $315 is grounded in a valuation multiple of approximately 16.8 times the expected EPS for the year 2025. The analyst underscored Willis Towers Watson's position as the most valuable among property and casualty (P&C) brokers, which contributed to the decision to maintain a Buy rating for the stock.

In other recent news, Willis Towers Watson has been the subject of several significant updates. Evercore ISI raised its price target for the company to $319, citing robust performance in organic growth, margins, and free cash flow.

TD Cowen also maintained a positive outlook on Willis Towers Watson, reiterating a Buy rating with a price target of $329.00. This followed a conversation with the company's CFO, Andrew Krasner, who expressed confidence in achieving the 2024 guidance.

BofA Securities upgraded its stance on Willis Towers Watson, moving from Underperform to Neutral, citing operational improvements. Keefe, Bruyette & Woods and CFRA adjusted their price targets for Willis Towers Watson to $311 and $275 respectively.

The company also announced a unique partnership with Ukrainian insurer VUSO, aiming to cover cargo and war-on-land risks in Ukraine.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.